相关实验视频
Updated: Jun 8, 2025

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
淋巴血管对于心脏功能和在败血症引起的心肌病的炎症解决是必要的
Cheng-Hua Wu1, Meng-Qi Guan2, Wei-Hua Lu2
1Department of Critical Care Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College); Anhui Province Clinical Research Center for Critical Respiratory Medicine, Anhui 241004, China; NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
通过血管内皮生长因子C (VEGF-C) 促进淋巴功能,改善心脏功能,并解决败血症诱导心肌病 (SICM) 中的炎症. 淋巴血管对于SICM的恢复至关重要.
科学领域:
- 心血管生物学 心血管生物学
- 淋巴体生理学 淋巴体生理学
- 败血症的发病原因
背景情况:
- 败血症诱导心肌病 (SICM) 是败血症的一个关键并发症,其特征是可逆的全球心脏功能障碍.
- 淋巴血管在液体平衡和炎症调节中起着至关重要的作用,但它们在SICM中的参与仍然未被探索.
研究的目的:
- 为了研究心脏淋巴血管在败血症引起的心肌病的作用.
- 评估血管内皮生长因子C (VEGF-C) 的治疗潜力,通过向淋巴细胞来改善SICM.
主要方法:
- 使用脂聚糖化物 (LPS) 挑战建立了SICM的小鼠模型.
- 进行了VEGF-C治疗,以评估其对心脏功能和淋巴血管的影响.
- 使用MAZ51抑制VEGFR-3被用于研究VEGF-C-VEGFR-3信号通路的作用.
主要成果:
- 败血症诱导心脏功能障碍和淋巴血管面积减少.
- VEGF-C治疗改善了心脏功能,增强了淋巴血管生成,并促进了中性粒细胞的清除.
- 抑制VEGFR-3会加剧心脏功能障碍,并阻断VEGF-C的保护作用,从而影响VEGF-C-VEGFR-3通路.
- 发现VEGF-C可以抑制MAPK信号通路在败血性心脏中.
结论:
- 功能性淋巴血管对于维持心脏功能和在SICM期间解决炎症至关重要.
- 向和促进淋巴功能为治疗败血症引起的心肌病症提供了一种新的治疗策略.
相关概念视频
Myocarditis I: Introduction
Rheumatic Heart Disease I: Introduction
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Pathophysiology of Heart Failure
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...

